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The nuclear receptor binding SET [su(var) 3-9,
enhancer of zeste, trithorax] domain-containing
protein 1 (NSD1) protein lysine methyltransferase
(PKMT) was known to methylate histone H3 lysine
36 (H3K36). We show here that NSD1 prefers aro-
matic, hydrophobic, and basic residues at the 2,
1 and +2, and +1 sites of its substrate peptide,
respectively. We show methylation of 25 nonhistone
peptide substrates by NSD1, two of which were
(weakly) methylated at the protein level, suggesting
that unstructured protein regions are preferred
NSD1 substrates. Methylation of H4K20 and p65
was not observed. We discovered strong methyl-
ation of H1.5 K168, which represents the best NSD1
substrate protein identified so far, and methylation
of H4K44 which was weaker than H3K36. Further-
more, we show that Sotos mutations in the SET
domain of NSD1 inactivate the enzyme. Our results
illustrate the importance of specificity analyses of
PKMTs for understanding protein lysine methylation
signaling pathways.
INTRODUCTION
The nuclear receptor binding SET [su(var) 3-9, enhancer of zeste,
trithorax] domain-containing protein 1 (NSD1; KMT3B) is a 2,696
amino acid long protein containing a catalytic SET domain sur-
rounded by several plant homeodomain (PHD) domains and
two proline-tryptophan-tryptophan-proline (PWWP) domains.
The SET domain has been found to introduce histone H3 lysine
36 (H3K36) mono- and dimethylation in vivo and in vitro (Raya-
sam et al., 2003), and the other domains are responsible for
mediating interactions with chromatin and other proteins (Huang
et al., 1998; Lucio-Eterovic et al., 2010; Rayasam et al., 2003).
Besides NSD1, the nuclear receptor binding SET domain
(NSD) histone lysine methyltransferase family consists of two
other proteins: NSD2 (WHSC1/MMSET) (Chesi et al., 1998;
Stec et al., 1998) and NSD3 (WHSC1L1) (Angrand et al., 2001).
Defects in NSD proteins lead to cancers such as acute myeloid
leukemia (AML), lung cancer, neuroblastomas, glioblastomas,226 Chemistry & Biology 21, 226–237, February 20, 2014 ª2014 Elseand genetic diseases such as Sotos and Wolf-Hirschhorn syn-
drome. Although the NSD enzymes share a similar architecture
of functional domains, they operate in distinct functional path-
ways. NSD1 is involved in postimplantation development; mice
deficient in NSD1 show embryonic lethality (Rayasam et al.,
2003). It binds to several promoter elements and regulates
many genes that have roles in development (Lucio-Eterovic
et al., 2010). Furthermore, via chromosomal translocation, it
forms fusion proteins in cancers, and nearly 5% of the human
AML patients contain the NUP98-NSD1 fusion oncoprotein
created by the fusion of NSD1 to the nucleoporin gene
(NUP98). The NUP98-NSD1 fusion protein targets H3K36
methylation activity to the Hox-A locus and enhances its expres-
sion (Wang et al., 2007). In addition, the NSD1 gene promoter is
silenced by hypermethylation in human neuroblastomas and
glioblastoma cells, and loss of NSD1 leads to an enhanced
expression of the ME1S1 oncogene (Berdasco et al., 2009).
Mutations in the NSD1 protein cause the Sotos syndrome, which
is characterized by severe overgrowth in childhood, facial abnor-
malities, and mental retardation (Leventopoulos et al., 2009).
Sotos mutations in the different PHD domains of NSD1 reduce
its binding to methylated histones, while mutations in the SET
domain impair its methylation activity on H3K36, suggesting
that they have an important role in disease pathogenesis (Pasil-
las et al., 2011; Qiao et al., 2011).
The NSD protein lysine methyltransferases (PKMTs) were re-
ported to methylate multiple lysine residues on histone proteins.
NSD2 has been reported to methylate H3K4, H3K27, H3K36,
H4K20, and H4K44 (Kang et al., 2009; Kim et al., 2006; Kuo
et al., 2011; Li et al., 2009; Marango et al., 2008; Pei et al.,
2011). NSD1 was initially reported to methylate H3K36 and
H4K20 (Rayasam et al., 2003). Later, contradicting data con-
cerning NSD1’s specificity were published: while one study
documented that NSD1 depletion did not alter the status of
H4K20 methylation (Yang et al., 2008), another reported that
reduced expression of NSD1 led to the reduction of H4K20
methylation (Berdasco et al., 2009). Similarly, controversial
data were reported for the H4K20 methylation activity of NSD2
(Hsiao and Mizzen, 2013; Marango et al., 2008; Martinez-Garcia
et al., 2011; Pei et al., 2011). Apart from histone substrates,
NSD1 recently was also reported to mono- and dimethylate
p65, an NF-kB family transcription factor, at K218 and K221,
which stimulates the expression of p65-dependent tumorigenic
genes (Lu et al., 2010). In summary, NSD1 has been observed
to methylate different substrate lysines in surprisingly variablevier Ltd All rights reserved
Figure 1. Activity of NSD1 Wild-Type and Sotos Mutants
(A) Sequence alignment of previously described substrates (H3K36, H4K20, p65) and some of the NSD1 substrates identified in this study (H4K44, H1.5K168).
(B) PKMT assay performed on H3K36 (31-50) wild-type and mutant peptides (K36 mutated to A). The figure shows an autoradiography image that indicates the
transfer of radioactively labeled methyl groups to the H3K36 peptide. The H3K36A peptide was not methylated.
(C) NSD1-Sotos mutations impair H3K36 methylation activity. Sotos mutant proteins were incubated with 1 mg of recombinant H3 protein in presence of
radioactively labeled AdoMet and the transfer of methyl groups detected by autoradiography. The Coomassie-stained gel shows the amount of different NSD1
mutants and wild-type NSD1 proteins used for methylation assays.
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about its mechanism of target lysine recognition.
To resolve the ambiguity on the substrate specificity of NSD1
and to further understand its substrate-specific recognition, we
characterized the substrate peptide sequence specificity of
NSD1 in detail by using peptide arrays synthesized on
cellulose membrane using the SPOT technique. Our results
demonstrate that NSD1 does not methylate H4K20, but instead
it methylates K44 of H4, albeit more weakly than H3K36. Further-
more, we found additional substrates of NSD1 that were not
described before, including both histone and nonhistone pro-
teins. We show that NSD1 strongly methylates K168 of H1.5
protein both in vitro and in cells. The rate of in vitro methylation
of H1.5 by NSD1 is about three times higher than that of
H3K36, the best NSD1 substrate known so far. In addition to
H1.5 K168, K168 of H1.2 and K169 of H1.3 are modified with
high efficiency, but no methylation of H1.4 was observed.
Furthermore, we show that Sotos mutations in the SET domain
of NSD1 reduce the activity of the enzyme, suggesting an epige-
netic deregulation in Sotos patients.
RESULTS
Activity of Wild-Type NSD1 and SOTOS Mutants
The glutathione S-transferase (GST)-fused SET domain of
mouse NSD1 was expressed in E. coli BL21 cells and purified.
To investigate the activity of the enzyme, peptide arrays were
synthesized on cellulose membrane, incubated with NSD1 and
radioactively labeled [methyl-3H]-AdoMet, and the transfer of
the methyl groups to the peptide was observed using autoradi-
ography. Since H3K36 was the best characterized NSD1 sub-
strate, we started our studies using the H3 (31–50) peptide and
its K36A mutant as substrates, and we observed that NSD1
methylates lysine 36 (Figure 1B). After purifying active NSD1,
we investigated the influence of four Sotos mutants within the
SET domain on NSD1 activity. We selected mutations at
R1952, R1984, R2017, and Y1997 out of all the Sotos mutations
known in the SET domain (Tatton-Brown et al., 2005); mutatedChemistry & Biology 21, 226the selected amino acids to those present in the Sotos patients
(R1952W, R1984Q, R2017W, and Y1997C); purified the corre-
sponding proteins; and tested their catalytic activity on the H3
protein. Our data show that all the four mutants completely lost
their ability to methylate H3 (Figure 1C). After we obtained
these experimental results, similar findings were published for
R1952W, R1984Q, and R2017Q (Qiao et al., 2011). Our results
extend this report, because we mutated R2017 to W, and the
Y1997C mutation was not included in the published work. Our
data combined with those of Qiao et al. (2011) indicate that the
Sotos mutants in the SET domain of NSD1 generally impair the
activity of the enzyme and suggest a probable epigenetic mech-
anism involved in the Sotos syndrome.
Specificity Profile of NSD1
To investigate the recognition of the H3K36 substrate by NSD1,
we used the H3 (31–50) containing the K36 methylation site and
individually exchanged the residues at positions 31–40 against
alanine to investigate their role in peptide recognition. The results
showed that the residues from 34–37 are important for activity
(Figure 2A), because an exchange of any of these residues
against alanine led to loss or reduction of the methylation signal.
Next, we synthesized peptide arrays by exchanging each amino
acid at every position of the H3 tail (31–49) against all 20 protei-
nogenic amino acids, in total leading to 380 peptides (Figure 2B).
As we described in our previous publications (Kudithipudi et al.,
2012; Rathert et al., 2008a), the relative methylation of each pep-
tide in the initial phase of the reaction is proportional to the cat-
alytic rate constant/dissociation constant value (kcat/KD) of
enzyme for the corresponding substrate, since the methylation
of different substrates occurs in competition in this
experimental set-up. Three independent membranes were syn-
thesized and methylated with NSD1. The results of the individual
experiments were normalized and averaged (Figure 2C). The
SDs observed for the individual peptides indicate that the data
are highly reproducible; in total about 85% of the substrates
showed a SD smaller than ±20%, andmore than 97%of the sub-
strates showed SDs smaller than ±30% (Figure S1 available–237, February 20, 2014 ª2014 Elsevier Ltd All rights reserved 227
Figure 2. Substrate Specificity of NSD1
(A) Alanine scan of H3 (31–49) peptides. In this assay, several positions of the H3 tail were exchanged individually against alanine and the peptides methylated by
NSD1. The first spot labeled with Wt contains the native sequence.
(B) Example of one complete H3 (31–49) peptide tail array. The horizontal axis displays the sequence of H3 tail, while the vertical axis represents the residues
(20 amino acids) used for the mutation of the corresponding residue. The image shows the relative efficiency of NSD1 methylation of each peptide.
(C) Compilation of the results of three independent peptide array experiments with NSD1. Data are averaged numbers from all three experiments after normalizing
full activity to 1.
(D) Bar diagram showing the discrimination factors of NSD1 at the positions tested.
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acid at each position of the H3 (31–49) peptide substrate, we
determined the discrimination factor (Figure 2D). As defined in
Experimental Procedures, this value provides a quantitative
description of the readout of the substrate peptide sequence
indicating the relative preferences for each residue at each
position. In agreement with the alanine scan experiment, the
specificity analysis shows that NSD1 mainly recognizes the H3
residues from 34 to 38. Our data show that NSD1 prefers aro-
matic residues at the2 position (considering K36 as position 0)
(F > Y >G); hydrophobic residues at1 (I > L > V); basic residues
at +1 (R > QKNM), where it cannot tolerate hydrophobic or aro-
matic residues; and hydrophobic residues at +2 (V > IA > P). At
other sites (like 3, +3, or +6), NSD1 prefers some amino acids,
but no strong residue specific readout was detected.
Methylation of Nonhistone Peptide Substrates by NSD1
Lysine methylation was initially discovered on histones (Murray,
1964), but an increasing number of reports show that lysine
methylation is a common posttranslational modification of pro-
teins comparable with acetylation and phosphorylation (Cao
et al., 2013; Huang and Berger, 2008; Moore et al., 2013). The
substrate specificity analysis of NSD1 indicates that, at some
positions, it prefers amino acids other than the residues found
in H3 at the corresponding position, which suggests that it might
also methylate additional proteins apart from H3K36. Moreover,
it was already reported that NSD1 methylates the p65 protein
(Lu et al., 2010). To identify additional substrates of NSD1, we
searched the Scansite database (Obenauer et al., 2003) with
the specificity profile of NSD1 obtained from our data, which re-
sulted in 315 human proteins containing potential NSD1 target
sites. Considering the localization and function of the NSD1 pro-
tein, we narrowed down the search to the nuclear localized
proteins. Along with several nonhistone substrates, we also
retrieved three histone proteins in this search as candidate sub-
strates of NSD1, which are H1.5 K168 and H4K44 in addition to228 Chemistry & Biology 21, 226–237, February 20, 2014 ª2014 Elsethe known H3K36 substrate. As a preliminary screening, we syn-
thesized peptides containing the predicted target lysine of all the
identified 47 nuclear candidate substrate proteins on a cellulose
membrane (Table S1). The membrane was subjected to methyl-
ation by NSD1, and of the 47 potential peptide targets, 27 were
methylated to the same extent or more than the histone H3K36
peptide (Figure 3A). Among all the newly identified peptide sub-
strates, the strongest methylation was observed on the H1.5
peptide containing K168. In addition to the histone substrates
H4K44 and H1.5K168, we found that NSD1 was able to meth-
ylate 25 additional nonhistone proteins at the peptide level. We
cloned several of these protein domains, managed to express
and purify 16 of them (printed in bold in Table S1), and found
that two of the nonhistone proteins (ATRX K1033 and U3 K189)
were methylated at the predicted target lysine (Figure 3B). How-
ever, the methylation of the nonhistone substrates was weak at
protein level, which led us to focus our work on the histone pro-
teins (Figure S3).
As mentioned earlier, it had been reported that NSD1 also
methylates the p65 protein (RelA) at K218 and K221 (Lu et al.,
2010). However, this conclusion was only based on the observa-
tion that methylation levels of p65 in cells were correlated with
NSD1 upregulation and knockdown. A direct methylation of
p65 by NSD1 was not shown. Since both p65 target lysine resi-
dues are embedded in a sequence context not fitting to our
experimental specificity profile (Figure 1A), we were interested
in investigating their methylation as well. To examine this, we
synthesized peptides containing H3K36 (29–43), p65 K218,
and K221 (212–226), and the corresponding lysine-to-alanine
variants. After methylation with NSD1, we observed a strong
methylation signal with the H3K36 peptide, but no methylation
was observed on the p65 (212–226) peptide (Figure 3C). Next,
we examined p65 methylation at protein level along with H3
and H4 proteins as positive controls. We observed strong
methylation of H3 and weaker methylation of H4, but no methyl-
ation was detectable on the purified p65 protein domainvier Ltd All rights reserved
Figure 3. Nonhistone Peptides and Protein
Methylation by NSD1
(A) Methylation of peptide NSD1 substrates. Pep-
tides (15 amino acids long) containing thepredicted
target lysine identified by the Scansite search with
the specificity profile of NSD1 were synthesized
and methylated with NSD1. Wild-type H3 (30–44)
and the corresponding K36A mutant peptide were
also added as controls, yielding in total 52 peptides
including the controls (the first two rows contain 21
peptides each, while the third row has 10 peptides).
Some of the peptides are labeled.
(B) NSD1 methylates two nonhistone proteins at
the predicted lysine residue. The purified tran-
scriptional regulator ATRX (ATRX) and probable
U3 snoRNA-associated protein 11 (U3) proteins
and the corresponding target lysine mutants were
incubated with NSD1 in the presence of radioac-
tively labeled AdoMet, and the methylation was
detected by autoradiography. WT, wild-type.
(C) No activity of NSD1 was observed on the p65
peptides. Activity of NSD1 was tested on the wild-
type p65 (212–226) peptide and on p65-K218A
and K221A mutant peptides. H3K36 wild-type and
mutant peptides were included as controls.
(D) Absence of NSD1methylation of the p65 protein
in vitro. Purified H3, H4, and p65 were incubated
with NSD1 in presence of radioactively labeled
AdoMet, and the methylation was detected by
autoradiography.H3wasmethylatedmore strongly
than H4, but no methylation was detectable on p65
protein; the positions corresponding to the target
proteins are highlighted by an asterisk.
See also Table S1.
Chemistry & Biology
Substrate Specificity and Novel Substrates of NSD1(Figure 3D), indicating that p65 was not methylated by NSD1
in vitro, neither at peptide nor at protein level.
Methylation of Histone H4 by NSD1
As mentioned earlier, NSD1 was reported to methylate H3K36
and H4K20 (Rayasam et al., 2003). While the results of our spec-
ificity analysis were not fitting to the H4K20 sequence, they are in
perfect agreement with the sequence context of another lysine
(position 44) in the H4 protein, because the H3K36 and H4K44
sites show high sequence similarity (Figure 1A). They share the
same residues at the 1, 2, and 3 positions and only differ
at the +1 position, where the H4K44 site has arginine instead
of lysine, which is in agreement with the NSD1 specificity profile.
To investigate if NSD1methylates H4K44 and/or H4K20, we syn-
thesized peptides 20 amino acids long containing the putative
target lysines H3K36 (H3 30–50), H4K20 (H4 10–30), and
H4K44 (H4 35–55) in the center and also the corresponding
mutant peptides with the target lysine exchanged to alanine.
The membrane was then methylated with NSD1. In agreement
with our specificity analysis, we did not observe any methylation
of the H4K20 peptide by NSD1, but we detected clear methyl-
ation of the H3K36 and H4K44 peptides and no methylation on
their corresponding target lysine mutant peptides (Figure 4A).
We next examined the methylation of H4 by NSD1 in solution
by MALDI analysis. For this, we synthesized the H4 (37–52) and
H4 (12–26) peptides, which contain the two potential target
lysines (K44 or K20), methylated the peptides with NSD1 in the
presence of unlabeled AdoMet, and subjected them to MALDIChemistry & Biology 21, 226analysis. With the H4 (37–52) peptide, we observed a mono-
methylation peak at +14 Da (1,801 Da) in addition to the unme-
thylated peptide peak at 1,787 Da (Figure 4B), indicating
monomethylation of H4K44 by NSD1. However, in accordance
with the peptide array experiments, we did not detect any meth-
ylated peak with H4K20 peptide (Figure S2). These observations
indicate that NSD1 does not methylate H4K20 in vitro, but
instead it methylates K44 of histone H4.
H1.5 Methylation by NSD1
The linker histone (H1) proteins have important roles in the estab-
lishment of condensed chromatin and in the regulation of gene
expression. In humans, 11 H1 variants exist, which exhibit cell
type and tissue-specific expression patterns. The H1.1 to H1.5
proteins show replication-dependent expression, and they are
present in all somatic cells, whereas other variants are restricted
to specific tissues (Happel and Doenecke, 2009; Happel et al.,
2009b). Similarly as the core histones, theH1proteins are subject
to several posttranslational modifications, but the biological role
of these modifications often is not known. The first methylation
site identified on an H1 protein was K26 of H1.4, which was
shown to be modified by EZH2 (Kuzmichev et al., 2004). Later,
G9a was shown to methylate H1.4 K26 (Rathert et al., 2008a;
Trojer et al., 2009) and H1.2 K187 (Weiss et al., 2010). In addition
to this, the human H1.2 protein has been reported to be methyl-
ated at K168, and this modification was reported to be increased
in cancer patients (Lu et al., 2009), but the responsible PKMT has
not yet been identified. As described earlier, the Scansite search–237, February 20, 2014 ª2014 Elsevier Ltd All rights reserved 229
Figure 4. Histone H4 Methylation by NSD1
(A) NSD1 methylates H4K44. NSD1 protein activity was examined on H3K36 (H3 30–50), H4K20 (H4 10–30), H4K44 (H4 35–55), and the corresponding target
lysine mutant peptides by incubating the peptide SPOT array with NSD1 in presence of radioactively labeled AdoMet and detection of the methylation signal by
autoradiography.
(B) MALDI analysis of the H4 (37–52) peptide in vitro methylation. The H4 (37–52) peptide was incubated with NSD1 in the presence of unlabeled AdoMet, and the
samples before and after methylation were analyzed using MALDI mass spectroscopy. Intens. [a.u.], intensity, in arbitrary units. The additional peak at 1801 Da
corresponds to the monomethylated form of the H4 (37–52) peptide.
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H1.5 as one putative additional substrate of NSD1 (Figure 3A).
It corresponds to the H1.2 K168 residue in the alignment of H1
isoforms. The H1.5 K168 site shares residues with the H3K36
site at the 1 and 2 positions and also at the +1 position.
Both peptides only differ at the +2 position, where theH1.5 target
carries a valine that fits even better to the specificity profile of
NSD1 than the proline present in the H3K36 site (Figure 1A).
These observationsmotivated us to examine the possible protein
methylation of H1.5 by NSD1.
To confirm themethylation of the predicted lysines, we synthe-
sized H3K36 (H3 30–44), H4K44 (H4 38–52), and H1.5 K168
(H1.5 161–175) substrate peptides and also the mutant peptides
with the corresponding target lysine exchanged to alanine. For
H1.5, the K169A mutant peptide was also included. We then
methylated the membrane with NSD1 (Figure 5A). As expected,
clear methylation signals were observedwith the H3K36, H4K44,
and H1.5 K168 peptides. The methylation signal of the H1.5
K169A mutant peptide was in par with the H1.5 wild-type pep-
tide, and no methylation signal was detected with the H1.5
K168 mutated peptide, which confirms that NSD1 methylates
the H1.5 peptide at K168. It is noteworthy that, by far, the stron-
gest NSD1 methylation was observed on H1.5, which is also in
accordance with our specificity profile data asmentioned earlier.
In fact, the strongest methylation signal of all 400 peptides
(including control peptides) in the H3 (31–49) peptide
sequence-based specificity profile was observed when the P
at +2 was exchanged with V (Figures 2B and 2C), which is the
residue that H1.5 carries at this place. To confirm themethylation
of H1.5 in solution, we synthesized the H1.5 (164–176) peptide
containing K168, methylated it with NSD1, and subjected it to
MALDI analysis. With the methylated sample, we observed an
additional 1,326.8 Da peptide peak along with the unmethylated
1,312.8 Da peptide peak (Figure 5B), which corresponds to the
monomethylated substrate (+14 Da). This result indicates that
NSD1 adds a single methyl group to H1.5 K168 under our exper-
imental conditions.230 Chemistry & Biology 21, 226–237, February 20, 2014 ª2014 ElseMethylation of NSD1 Histone Targets by SETD2
Since both of the NSD1 histone targets discovered here (H1.5
K168 and H4K44) show sequence similarity to H3K36, we were
interested in investigating whether they are specific for NSD1
or whether other H3K36 methyltransferases methylate them
as well. Therefore, we measured the activity of SETD2 (HYPB),
another H3K36 methyltransferase (Edmunds et al., 2008), on
the newly identified substrates.With SETD2, we observed strong
methylation on H3K36 but only very weak methylation of the
H1.5 K168 and H4K44 peptides, indicating that the NSD1 sub-
strates described here were not methylated efficiently by this
H3K36 methyltransferase (Figure S4).
Variant-Specific H1 Methylation by NSD1
To investigate whether NSD1 methylates H1 proteins other than
H1.5, we synthesized 15-amino-acid long peptides of H3 and
H4, and variants of H1 fromH1.2 toH1.5, alongwith the predicted
target lysine mutants (note that in H1.3 and H1.4, K169 corre-
sponds to K168 in H1.5). After incubation with NSD1, a strong
methylation signal of the H1.3 K169 and H1.5 K168 peptides
was observed; moderate signals were detected with the
H3K36, H4K44, and H1.2 K168 peptides; and loss of methylation
signal was seen with all target lysine mutants. No methylation of
the H1.4 K169 peptide was detected (Figure 5A). This result sug-
gests that NSD1 exhibits H1 variant-specific methylation. We
used recombinant untagged H1 proteins (H1.2, H1.3, H1.4, and
H1.5) to perform in vitro protein methylation assays. The methyl-
ation of H1 variants by NSD1was analyzed by incubating the pro-
teinswithNSD1 in reaction buffer containing radioactively labeled
AdoMet. The proteins were then separated by SDS-PAGE, and
the transfer of methyl groups to the H1 proteins was analyzed us-
ing autoradiography (Figure 5C).We detected a strong incorpora-
tion of methyl groups into the H1.5 protein. Less methylation was
observed with H1.2 and H1.3, and no signal was seen on H1.4
protein, which fully agreeswith the results obtained in the peptide
methylation. The incapability of NSD1 to methylate H1.4 can be
explained on the basis of the specificity profile, because NSD1vier Ltd All rights reserved
Figure 5. NSD1 Methylates H1 Proteins in a Variant-Specific Manner
(A) NSD1 methylation activity was tested on the different variants of H1 peptides and corresponding mutants with the predicted target lysine exchanged to
alanine: H1.5K168 (161–175), H1.2K168 (160–174), H1.3K169 (161–175), and H1.4K169 (161–175). The H3K36 (29–43) and H4K44 (38–52) peptides were
included as control. The target lysine of the specific peptide is underlined.
(B) In vitro methylation of the H1.5 (164–176) peptide detected by mass spectrometry. The H1.5 (164–176) peptide was incubated with NSD1 in the presence of
unlabeled AdoMet, and the samples before and after methylation were analyzed by MALDI mass spectroscopy. Intens. [a.u.], intensity, in arbitrary units. The
additional peak at 1326.8 Da corresponds to the monomethylated form of the H1.5 (164–176) peptide.
(C) In vitro methylation of recombinant untagged histone H1 proteins by NSD1.
(D) NSD1methylates GST-tagged H1 proteins at the predicted lysine residue. GST-H1 proteins and the corresponding target lysine mutants were incubated with
NSD1 in the presence of radioactively labeled AdoMet, and methylation was examined by autoradiography. WT, wild-type.
(E) NSD1 shows high activity on H1.5K168. Biotinylated peptides of H3 (26–44), H1.5 (160–178), and H4 (36–54) were incubated with NSD1 in the presence of
radioactively labeled AdoMet, and the transfer of methyl groups to the peptides was quantified by scintillation counting. The figure shows average activities and
their SEs based on two experiments.
(F) Comparison of NSD1 activity on recombinant unmodified nucleosomes (Zhang et al., 2010) and purified H3 and H1.5 proteins. The protein substrates were
incubated with NSD1 in the presence of radioactively labeled AdoMet, and the methylation was analyzed by autoradiography.
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tein has an A at this site, which, in the specificity analysis, led to a
complete loss of activity. Furthermore, NSD1 strongly prefers V at
the +2 position, which fits to the sequence of H1.2, H1.3, and
H1.5 but not to that of H1.4, which carries an A at this place.
Taken together, these results demonstrate that NSD1methylates
H1 lysine residues in a variant-specific manner that can be ex-
plained on the basis of the specificity profile.
The H1 proteins are highly basic and contain several lysine
residues. To confirm that the methylation was occurring on theChemistry & Biology 21, 226target lysine residues, we exchanged the target lysines in all
three H1 variants (H1.2, H1.3 and H1.5) to arginine. To this
end, we cloned the H1 proteins in a GST expression vector
and introduced the target lysine-to-arginine exchanges by site
directed mutagenesis. The wild-type and mutated H1 proteins
were subsequently overexpressed in E. coli and purified by affin-
ity chromatography. All the three wild-type GST tagged H1
proteins could be methylated by NSD1, but no methylation sig-
nals were detected on their corresponding target lysine mutants
(Figure 5D). These results demonstrate that NSD1 catalyzes a–237, February 20, 2014 ª2014 Elsevier Ltd All rights reserved 231
Figure 6. H1.5 Is Methylated by NSD1 in
HEK293 Cells
Flag-tagged H1.5 proteins were transiently ex-
pressed in the absence andpresenceof ectopically
expressed NSD1. H1 proteins were purified and
separated on SDS-PAGE. The flag-tagged H1.5
proteinswerecut fromthegel, and theirmethylation
was analyzed by MALDI after tryptic digestion.
(A) The mass spectrum obtained from the H1.5
protein purified from the cells without coex-
pression of NSD1.
(B) The mass spectrum from the H1.5 protein pu-
rified from cells with ectopically expressed NSD1.
In (A), we detected the peptide containing the
unmethylated K168 (KPAAAGVKme0KVAKSPK,
theoreticalmass: 1,479.9Da). This peptidewasnot
observed in (B), but the same peptide with an
additional mass of +14 Da corresponding to the
monomethylated form (KPAAAGVKme1KVAKSPK,
theoretical mass 1493.9 Da) was detected. In
addition, we observed some common peaks
(1,482.9 Da, 1,488.9 Da and 1,496.9 Da) in both
spectra.
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H1.5 and H1.2 and K169 in H1.3.
Cellular Methylation of H1.5K168 by NSD1
To investigate the specific methylation of H1.5 K168 by NSD1 in
cells, we transfected HEK293 cells with H1.5 in the absence and
presence of additionally cotransfected NSD1. The H1 proteins
were purified by acidic extraction and separated by SDS-PAGE
(Figure S5). Then, the H1.5 protein bands were cut out and di-
gested in gel with trypsin. Afterward, the peptides were eluted
from the gel, and the methylation was investigated using MALDI
mass spectroscopy. As expected, the overall spectrum allowed
us to identify H1.5 with a very good score (p < 0.05) and 60%–
70% protein sequence coverage (Figures 6A and 6B). We identi-
fied the unmethylated peptide containing K168 (amino acids
161–175 corresponding to a mass of 1,479.9 Da) after tryptic
digestion of the H1.5 protein purified from cells without NSD1
cotransfection. In contrast, this peptide was not detected after
digestion of the H1.5 protein purified from HEK293 cells cotrans-
fected with NSD1. Instead, in this sample, the same peptide with
an additional +14 Da was found (1,493.8 Da), corresponding to
themonomethylated form of the peptide. In addition to themeth-
ylated and unmethylated amino acid 161–175 peptide peaks, we
observed an unmethylated amino acid 160–168 peptide peak of
741.46 Da in both the samples. This peak cannot be expected in
methylated form, because methylation of K168 inhibits the
trypsin cleavage at this site. We conclude that the H1.5 protein
was methylated at K168 in cells when it was cotransfected
with NSD1; however, no methylation was detected without232 Chemistry & Biology 21, 226–237, February 20, 2014 ª2014 Elsevier Ltd All rights reservNSD1 cotransfection, indicating that the
methylation was introduced by NSD1.
H1.5 K168 versus H3K36
Methylation
In all our peptide array experiments,
we observed that the methylation ofH1.5K168 was much more efficient than the methylation of
H3K36 and H4K44. To determine the efficiency of NSD1 methyl-
ation of H1.5 K168 and H3K36 with soluble peptides, we per-
formed in vitro methyltransferase assay with three biotinylated
peptides, viz. H3 (26–44) containing H3K36, H1.5 (160–178)
containing H1.5K168, and H4 (36–54) containing H4K44. We
incubated the peptides with NSD1 in presence of radioactively
labeled AdoMet and observed the transfer of labeled methyl
groups to the corresponding peptides using scintillation count-
ing (Figure 5E). The results were in agreement with our peptide
array experiments, showing the highest methylation of H1.5
K168 followed by H3K36 and weaker methylation of H4K44.
The methylation of H1.5 K168 was 3.2-fold higher than H3K36.
Finally, we also compared the activity of NSD1 on purified H3,
nucleosomal histones (where we detected methylation of H3
and H4) and purified H1.5 protein (Figure 5F). Similarly, as seen
with NSD2 (Kuo et al., 2011; Li et al., 2009), H3 methylation
was stronger in the nucleosomal context than with the purified
H3 protein. However, the purified H1.5 protein was, by far, the
most active substrate. Together with our specificity profile
and peptide array experiments, this result strongly suggests
that H1.5 K168 is the most preferred substrate for NSD1 known
so far.
DISCUSSION
Methylation of H3K36 has been observed with several human
PKMTs, including NSD1 (Li et al., 2009; Rayasam et al., 2003),
NSD2 (Kuo et al., 2011; Li et al., 2009), SMYD2 (Brown et al.,ed
Figure 7. Superimposition of DIM-5 and
NSD1
AdoMet and the H3K9 peptide are shown in yellow
and blue, respectively. The superimposition was
prepared using 604 backbone atoms with a root-
mean-square deviation of 1.2 A˚.
(A) DIM-5 (Protein Data Bank [PDB] entry 1PEG)
(green) and NSD1 (PDB entry 3OOI) (red) are
shown as cartoons according to their secondary
structure elements.
(B) Enlargement of the structure showing NSD1 as
red Ca-trace. The H3K9 peptide only shows the
Cß atoms for the1 (cyan) and +1 position (green).
The +2 V is shown in pink. The 1 position of the
peptide is in close proximity to L2063 of NSD1 (Ca
shown in cyan). The +1 position approaches
E2061 (Ca shown in green), and the +2 position approaches L1999 and L2040 (shown in pink). Note that the numbering in the NSD1 structure differs from the
numbering of human NSD1 used in this article. L1999 corresponds to L148 in the numbering of 3OOI, L2040 to L189, E2061 to E210, and L2063 to L212.
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2007). This raises the question of why somany different enzymes
are available for the methylation of the same target residue. One
explanation could be that the product specificities of these
enzymes differ as exemplified by the finding that NSD1 and
NSD2 only monomethylate and dimethylate their substrate,
while SETD2 can introduce up to three methyl groups producing
H3K36me3. Another possibility could be that H3K36 is not the
only—and perhaps not even the major—physiological substrate
for some of these enzymes. We have developed a strategy for
identifying novel methylation substrates of PKMTs (Dhayalan
et al., 2011; Kudithipudi et al., 2012; Rathert et al., 2008a,
2008b), which follows four principal steps: (1) we first determine
the specificity profile of the PKMT to define which residues are
possible and preferred at all sites of the substrate peptide; (2)
then, we use the profile to identify novel candidate substrates
bioinformatically and investigate themethylation of putative sub-
strates at peptide level; (3) next, we investigate the methylation
of novel substrates at protein level and (4) investigate if the
PKMT methylates the novel target in human cells. The NSD1
enzyme had been reported previously to methylate H3K36 and
H4K20 (Rayasam et al., 2003) and two sites on p65 (Lu et al.,
2010). It is interesting that these lysine residues are situated in
very variable sequence contexts (Figure 1A), which raised ques-
tions about the mechanism of target peptide recognition by
NSD1 and made a detailed analysis of peptide recognition by
this enzyme particularly relevant.
We conducted a specificity analysis of NSD1 using the
sequence of H3K36 as the template and show that this enzyme
prefers hydrophobic residues at the2 (F > Y > G),1 (I > L > V),
and +2 (V > IA > P) positions of the substrate peptide sequence.
At the +1 position, NSD1 prefers positively charged residues (R >
QKNM), and it does not tolerate hydrophobic or aromatic resi-
dues at this site (Figure 2). To better understand the molecular
basis of our results, we superimposed the NSD1 structure
(Qiao et al., 2011) with the structure of the DIM-5 PKMT, which
contains a bound H3K9 target peptide (Figure 7). DIM-5 was
selected as the structural template because of its high structural
similarity to NSD1. Although DIM-5 is bound to the H3K9 pep-
tide, this superimposition allowed us to identify some of the res-
idues of NSD1 that might interact with the target peptide. The1
position of the peptide is in close proximity to L2063 of NSD1,Chemistry & Biology 21, 226and the +2 position comes close to L1999 and L2040 of NSD1,
which can explain the preferences for hydrophobic residues at
these sites. In contrary, the +1 position approaches E2061 of
NSD1, which may explain the preference for R, Q, and K at this
site. The 2 position of the K9 peptide overlaps with the back-
bone of NSD1, indicating that the NSD1 target peptide must
have a different conformation than the H3K9 peptide bound to
DIM-5 or the NSD1 has to undergo a conformational change,
as proposed by Qiao et al. (2011). Besides this, we conclude
that the specificity profile is in good agreement with the struc-
tural data of NSD1.
Our data show that NSD1 does not methylate H4K20 in vitro,
which had been described as one NSD1 target. Based on our re-
sults that the H4K20 sequence does not fit to the substrate spec-
ificity of NSD1 and that the enzyme rather methylates H4K44,
H4K20methylation by NSD1 in vivo is very unlikely. The proposal
that NSD1 might methylate H4K20 was based on the observa-
tion that NSD1 methylates the H4 protein in vitro, as found using
a radioactive methylation assay (Rayasam et al., 2003). This
methylation could occur anywhere on H4 (including K44), but
at that time, K20 was the only known methylation site on the
H4 N-terminal tail. Then, an H4K20me2 antibody was used to
confirm the target site, but the signal obtained in that experiment
might be due to a cross-reactivity of the antibody with
H4K44me2. Loss of the methylation signal with a K20A variant
of H4 was not reported. Later, it was also shown that loss of
NSD1 activity in cells was correlated with the reduction of
H4K20 methylation (Berdasco et al., 2009), but these effects
could be connected indirectly, and in another study, depletion
of NSD1 did not alter H4K20 methylation (Yang et al., 2008).
We show that NSD1 in vitro methylates K44 of H4 instead of
K20 suggesting that either it changes its specificity in cells or
the reduction of H4K20 methylation was only indirectly con-
nected to the loss of NSD1 activity. Methylation of H4K44 is in
agreement with mass spectrometric detection of H4K44 mono-
methylation in cells (Zhang and Freitas, 2004). It is interesting
that the NSD2 protein also methylates H4K44 (Li et al., 2009),
albeit methylation was only observed on histone octamers but
not on nucleosomes in vitro (Li et al., 2009; Qiao et al., 2011).
Therefore, it remains to be investigated whether NSD1 and
NSD2 have a role in H4K44 methylation in cells or whether
another enzyme might introduce this modification.–237, February 20, 2014 ª2014 Elsevier Ltd All rights reserved 233
Chemistry & Biology
Substrate Specificity and Novel Substrates of NSD1In addition to H4K20, NSD1 had been reported previously to
methylate two lysine residues on p65 (Lu et al., 2010). Lu et al.
(2010) showed methylation of these lysine residues on p65, and
this methylation was strongly influenced by overexpression and
knockdown of NSD1, but direct in vitro evidence that p65methyl-
ation is caused by NSD1 was not provided. As in H4K20, the
target lysines on p65 are situated in a sequence context that
does not fit to the specificity of NSD1. Indeed, we could not
detect methylation of the corresponding peptides and the p65
protein in vitro. We conclude that either NSD1 changes its spec-
ificity in cells, or the connection of cellular p65 methylation and
NSD1 was indirect. Our results underscore the importance of
dedicated specificity analyses of PKMTs to decipher protein
lysine methylation signaling pathways and networks. It is inter-
esting to note that detailed specificity studies of NSD2 resulted
in a similar finding as reported here for NSD1, namely, that
some previously reported target sites including H4K20 could
not be verified (Kuo et al., 2011; Li et al., 2009).
Based on our specificity profile of NSD1, we discovered 25
nonhistone substrates of NSD1 that were methylated strongly
at the peptide level. Sixteen of the putative substrates could
be prepared as proteins or protein domains, but only two of
them (ATRX K1033 and U3 K189) were methylated at the protein
level, and this methylation was very weak in both cases. The
weak activity of NSD1 for methylation of folded proteins may
be correlated to the predominance of hydrophobic residues in
its specificity profile, which normally are not exposed in folded
proteins and, consequently, not available for interaction. Our
data suggest that flexible peptides in unstructured protein parts
or in unfolded proteins are preferred substrates of NSD1.
Methylation of H1.2 K168 has been reported before (Lu et al.,
2009), but the responsible PKMT could not be identified. We
identified histone H1 as a potential NSD1 substrate and show
that K168 of H1.5 and H1.2, as well as K169 of H1.3, are strongly
methylated by NSD1 both at the peptide and the protein levels.
Cellular methylation of the H1.5 protein was confirmed by
mass spectrometry after cotransfection with NSD1. While we
cannot exclude an indirect effect of NSD1 contransfection, the
fact that we observed cellular methylation of H1.5 at K168, which
is the best in vitro substrate of NSD1, makes it very likely that
this methylation is directly caused by NSD1. While we cannot
exclude an indirect effect of NSD1 contransfection, the fact
that we observe cellular methylation of H1.5 at K168, which is
the best in vitro substrate of NSD1, makes it very likely that
this methylation is directly caused by NSD1. In vitro, methylation
of H1.5 ismore efficient thanmethylation of the previously known
H3K36, whichmakes H1.5 themost preferred substrate of NSD1
known so far. It will be interesting in the future to determine if H1
is also methylated by NSD1 when it is bound to chromatin. In
addition, the biological functions of H1.5 K168 methylation
need to be investigated, as well as the probable crosstalk
between themethylation of H1.5 K168 andH3K36. Our data con-
nect NSD enzyme with the methylation of H1 histone proteins,
which expands their possible biological role.
We also confirm the finding that the Sotos mutants in the cat-
alytic domain of NSD1 impair its activity (Qiao et al., 2011).
Whether the loss of H3K36 methylation or loss of methylation
of one of the H1 NSD1 substrates that we identified here is
responsible for the broad developmental defects associated234 Chemistry & Biology 21, 226–237, February 20, 2014 ª2014 Elsewith the Sotos syndrome remains to be studied. Based on our
results, the investigation of changes in H1 methylation in Sotos
patients appears to be a promising direction for future follow-
up studies. Together with recent data showing that a Sotos
mutation in the NSD1-PHD domain inhibits its binding to the
methylated lysines (Pasillas et al., 2011), our results strongly
suggest an important epigenetic malfunctioning in the Sotos
syndrome patients.
SIGNIFICANCE
The NSD1 protein lysine methyltransferase has been re-
ported to methylate H3K36, H4K20, and two lysines on the
NF-kB family member p65. Using peptide arrays, we studied
the specificity of NSD1 showing that the enzyme prefers
defined aromatic and hydrophobic residues at the –2, –1,
and +2 positions (with respect to the target residue) and
that it prefers positively charged residues at the +1 position.
We identified 25 nonhistone peptide substrates of NSD1, but
only two of them (ATRX K1033 and U3 K189) showed weak
methylation at protein level. The less efficient methylation
of folded proteins may be correlated to the hydrophobic
specificity profile of NSD1, suggesting that unstructured or
unfolded protein regions may be preferred substrates. We
discovered two histone substrates of NSD1 in addition to
H3K36, which was known before. H4K44 is methylated
more weakly than H3K36, but H1.5 K168 is methylated
much more strongly than H3K36, and it represents the best
NSD1 substrate identified so far. Methylation of H1 isoforms
by NSD1 was confirmed in cells and may have a role in the
control of chromatin structure. NSD1 methylation of H4K20
and p65 was not observed at peptide or protein level. We
conclude that either NSD1 changes its specificity in cells
or the previously observed connection of cellular p65 and
H4K20 methylation and NSD1 was indirect. Our results un-
derscore the importance of specificity analyses of PKMTs
for the understanding of protein lysinemethylation signaling
pathways and networks. We observed that the Sotos syn-
drome mutants of NSD1 in the catalytic domain impair its
activity. Based on our results, the investigation of changes
in H1 methylation in Sotos patients appears to be a prom-
ising direction for future follow-up studies.
EXPERIMENTAL PROCEDURES
Cloning, Expression, and Purification of Proteins
The coding regions of H1 proteins H1.2 (amino acid residues 19–212 of UniProt
entry P16403), H1.3 (amino acid residues 18–216 of P16402), and H1.5
(P16401); SETD2 (amino acid residues 939–1,195 of Q9BYW2); Probable U3
snoRNA-associated protein 11 (amino acid residues 120–243 of Q9Y3A2);
ATRX (amino acid residues 911–1,118 of P46100); and p65 (amino acid resi-
dues 191–450 of Q04206) were amplified from cDNA prepared from HEK293
cells and cloned into PGEX-6P-2 vectors for bacterial protein expression.
The target lysine mutations in H1.2 (K168R), H1.3 (K169R), H1.5 (K168R),
ATRX (K1033R), and Probable U3 snoRNA-associated protein 11 (K189R)
were introduced by using PCR-megaprimer mutagenesis (Jeltsch and Lanio,
2002). The GST-tagged SET domain of mouse NSD1 for bacterial protein
expression (amino acid residues 1,700–1,987 of 088491.1) and a Flag-tagged
mouse NSD1 construct for mammalian expression (amino acid residues 1–
2,588 of 088491.1) were obtained as kind gifts from Professor Pierre Chambon
(Nielsen et al., 2004; Rayasam et al., 2003). The SET domains of mouse andvier Ltd All rights reserved
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catalytic domain of mouse NSD1. They are referred by the corresponding hu-
man amino acid numbers in the text. For the generation of a Flag-tagged fusion
construct of H1.5, the coding region for human H1.5 was cloned into the
expression vector pFlag-CMV-5-1 (Sigma) as described elsewhere (Happel
et al., 2009a).
Proteins were expressed in Escherichia coli BL21 cells (Novagen) grown in
Luria-Bertani media at 37C with continuous shaking until they reached 0.8
optical density 600 nm. Then, the cells were shifted to 22C for 15min, induced
with 1 mM isopropoyl-beta-D-thiogalactopyranoside and grown for 10–12 hr.
Protein purification was performed as described elsewher (Dhayalan et al.,
2011). For eukaryotic expression, the expression plasmids were transiently
transfected into human HEK293 cells using FuGENE HD (Promega). Two
days after the transfection, the cells were harvested and the H1 proteins
were purified as described later. Recombinant expression of human H1 sub-
types in yeast cells was performed as described elsewhere (Albig et al., 1998).
Synthesis of Peptide Arrays and Peptides
Peptide arrays were synthesized on cellulose membrane by the SPOT
synthesis method using a Multipep system (Intavis AG). Each spot contained
approximately 9 nmol peptide (Autospot Reference Handbook, Intavis AG).
Successful synthesis of peptides on the membrane was confirmed by bromo-
phenol blue staining. Peptides for the solution experiments were synthesized
with Multipep system (Intavis AG) using Fmoc solid-phase peptide chemistry.
Biotinylated peptides were commercially supplied by Intavis AG.
In Vitro Peptide and Protein Methylation
Themembranescontaining thepeptideswerewashed for 20min inmethylation
buffer containing 50mMTris-HCl (pH9.0), 5mMMgCl2, and 4mMdithiothreitol
(DTT) and incubated at room temperature for 60 min in methylation buffer con-
taining 50 nM NSD1 and 0.76 mM labeled [methyl-3H]-AdoMet (Perkin Elmer).
Imaging and analysis was performed as described elsewhere (Kudithipudi
et al., 2012; Rathert et al., 2008a, 2008b). Biotinylated peptide methylation re-
actions were performed as described elsewhere (Gowher et al., 2005). Protein
methylation reactions were performed in methylation buffer with 0.76 mM
tritium-labeled AdoMet. Target proteins (2 mM) were incubated with 100 nM
NSD1 for 4 hr at 37C. Reactions were stopped by boiling with SDS loading
buffer at 95C for 5min. Afterward, the sampleswere run on 16%or a specified
percentage of SDS-PAGE, and the methylation was detected by autoradiog-
raphy. For mass spectrometry experiments, the peptides were incubated in
methylation buffer comprising 50 mM Tris-HCl (pH 9.0), 5 mM MgCl2, and
4mMDTTwith 100 nMNSD1 and 1mMAdoMet for 4 hr at 37C. The reactions
were stopped by diluting the sample in 0.1% trifluoroacetic acid (TFA). The
methylation of the peptides was assessed by mass spectrometry using a
Bruker Autoflex Speed MALDI-TOF system as described later.
Peptide Array Data Analysis
The complete specificity scan peptide array methylation experiments were
performed three times and the results normalized. Data are reported as
mean values and SEs. To analyze and describe the accuracy of recognition
of each residue in the substrate peptide quantitatively, the relative preference






where vi is the rate of methylation of the peptide variant carrying amino acid i at
position x, and vjsi is the average rate of methylation of all 19 peptides carrying
a different amino acid jsi at position x (including the wild-type sequence). We
considered 3% of the full activity as a background; the discrimination factor of
K36, which cannot be substituted by any amino acid, was 35 (Rathert et al.,
2008b).
Purification of Endogenous and Epitope-Tagged Histone H1
Proteins
Histone H1 proteins were purified from HEK293 cells by the perchloric acid
extraction method (Happel et al., 2005). About 5 3 107 cells were harvested
by centrifugation (1,000 rpm for 5 min), and the cell pellet was washed withChemistry & Biology 21, 226PBS (PAA Laboratories). The cell pellet was resuspended in perchloric acid
(PCA) (0.83 M) and incubated for 1 hr at 4Cwith continuous rotation. Samples
were centrifuged (14,000 rpm for 10 min), and the supernatant containing the
acid-soluble proteins was collected and precipitated with trichloroacetic acid
(20% final concentration) for 1 hr at 4C. To collect the precipitated proteins,
we centrifuged the samples (14,000 rpm) for 30 min. Finally, the pellet was
washed with ice-cold acetone five times and air dried. The purified histones
were dissolved in 10 mM HCl. The H1 histone proteins expressed in yeast
were extracted using 0.83 M PCA as described elsewhere (Kratzmeier et al.,
1999) and further purified by gel filtration using a Biogel P60 column (Bio-Rad).
Mass Spectrometry of Methylated Histone Proteins
Histone protein bands were excised from the SDS gel. The gel pieces were de-
stained with 50 mM ammonium bicarbonate and 100% acetonitrile in a 1:1
mixture, incubatedwith100%acetonitrile, and lyophilized. The lyophilized sam-
ple was disolved in 30 ml of buffer (40 mM ammonium bicarbonate and 10%
acetonitrile) containing 5 ng/ml trypsin (Promega) and digested overnight at
37C. Peptides were extracted with extraction buffer (25% acetonitrile in
0.1% TFA), dried by vacuum centrifugation, and dissolved in 0.1% TFA for the
analysis. Sample preparation was conducted following the dried droplet proto-
col (Shevchenko et al., 2006). The tryptic digest (1 ml) was spotted on onewell of
an MTP AnchorChip 384 TF plate (Bruker) and completely dried. Then, 1 ml of
HCCA matrix (0.7 mg/ml a-cyano-4 hydroxycinnamic acid dissolved in 85%
acetonitrile, 0.1% TFA, 1 mM ammonium dihydrogen phosphate) was added,
and the sample againwasdried.MALDI analysiswasperformedwith theBruker
Autoflex Speed MALDI-TOF system, which has a mass accuracy of%2 ppm.
The spectra were collected in the mass-to-charge ratio 500–3,500 Da range in
reflector mode. The system was calibrated with a peptide calibration standard
(Bruker), with peptides covering masses of 700–3,200 Da. The spectra were
collected using flexControl and flexAnalysis software (Bruker). Processed
spectra were analyzed using Mascot search and Biotools (Bruker) by setting
theprecursor ion tolerance to50ppm.Monomethylation (masschange,+14.016
Da), dimethylation (28.0313 Da), and trimethylation (42.047 Da) of lysine; acety-
lation (42.011Da)of lysine;andoxidation (15.995Da)ofmethioninewereconsid-
ered as possible modifications in the interpretation of spectra.
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